MedPath

A study to compare two different doses of brachytherapy in endometrial cancer

Phase 3
Not yet recruiting
Conditions
Health Condition 1: C541- Malignant neoplasm of endometrium
Registration Number
CTRI/2022/03/041034
Lead Sponsor
Post Graduate Institute of Medical Education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Age >18 years

2. ECOG 0-1

3. Histologically confirmed cases of Endometroid endometrial carcinoma

Exclusion Criteria

1. Poor performance status

2. Serous or clear cell carcinoma endometrium, sarcoma or carcinosarcoma

3. Stage >1, stage 1a grade 1

4. Uncontrolled Comorbidities

5. No prior history of pelvic radiotherapy

6. Residual macroscopic disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath